Psychedelic‑Assisted Therapies: Emerging Evidence, Ethical Challenges, and Future Directions

October 14, 2026 @ 12 PM CT

Psychedelic-assisted therapies are gaining increased attention for their potential role in treating psychiatric and substance use disorders. This session provides an overview of studied psychedelic compounds and their proposed mechanisms of action. Participants will review current research findings, therapeutic models, and safety considerations, as well as the significant regulatory, ethical, and cultural issues surrounding these treatments. The presentation emphasizes maintaining professional standards while navigating emerging evidence and heightened public interest.

Featured On-Demand Programs

Recorded Buprenorphine for Opioid Use Disorder: Clinical Effectiveness, Safety, and Access

Explore the clinical effectiveness, safe use, and accessibility of buprenorphine for opioid use disorder. This recorded session also addresses treatment strategies, stigma, regulatory considerations, and barriers to patient care

Recorded 2026 LIVE @ LUNCH - From Quick Prompts to Custom Bots: Practical AI for Pharmacy

Discover practical ways artificial intelligence can save time and support pharmacy practice in this recorded LIVE @ LUNCH session. Participants will explore simple, ready-to-use prompts as well as custom pharmacy bots designed for tasks such as summarizing guidelines, creating patient education materials, answering drug information questions, and assisting with documentation. The session emphasizes practical implementation, safety, and ethical AI use across pharmacy settings.

Recorded Spring Preceptor Kickoff: Key Plays for a Successful Experiential Education Year

This one‑hour webinar will serve as the Auburn University Harrison College of Pharmacy Experiential Programs Office’s (EPO) Experiential Year Kickoff, combining essential program updates with practical, immediately applicable precepting strategies. The session is designed to:

• Align preceptors with current experiential expectations and key resources
• Equip preceptors with concise, high‑impact teaching and coaching tools
• Strengthen engagement and connection between preceptors and the EPO

Recorded Electronic Cigarettes and Vaping: What Every Pharmacy Professional Needs to Know

A fast, practical look at vaping: Explore the rise of e‑cigarettes, the real health risks, and whether they truly help with quitting smoking, while gaining clear, actionable guidance to support patients who want to stop vaping.

LAW SERIES:

Laws and Rules Governing Pharmacy-Related Entities in Alabama | Harrison College of Pharmacy

Pharmacy as a Profession in Alabama: Relevant Laws and Rules | Harrison College of Pharmacy

This CE presentation reviews Alabama-Specific pharmacy laws, rules, and regulations relevant to the profession including the Board of Pharmacy, pharmacy personnel licensure, and scope of practice important for a pharmacist to know and for review of the MPJE.

Laws Regarding Controlled Substances and the Controlled Substance Act

This CE presentation reviews federal, as well as Alabama-specific, pharmacy laws, rules, and regulations that pertain to controlled substances. These laws, rules, and regulations apply to pharmacists practicing throughout the Alabama health-system. Knowledge of this information is required in order for pharmacists to successfully pass the Alabama MPJE.

Laws Governing Prescriptions and Medications

This CE presentation reviews federal, as well as Alabama-specific pharmacy laws, rules, and regulations that pertain to prescriptions and medications. These laws, rules, and regulations apply to pharmacists practicing throughout the Alabama health-system. Knowledge of this information is required in order for pharmacists to succesfully pass the Alabama MPJE.

Understanding Pharmacy Laws and Rules Governing the Health System and Hospitals in Alabama

This CE presentation reviews Alabama-Specific pharmacy laws, rules, and regulations relevant to health-system and hospital settings which are important for a pharmacist to know and for review of the MPJE.

Understanding Federal Pharmacy Law

This CE presentation reviews federal pharmacy laws, rules, and regulations important for a pharmacist to know and for review of the MPJE.

Recent Updates for the Management of Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the development of antimicrobial resistance.

Complementary and Alternative Medicine: A Path to Holistic Healing

This webinar will introduce pharmacists to common complementary health approaches used by patients, including nutritional, psychological, and physical approaches. Information about regulations for dietary supplements and homeopathy will also be covered. Case examples will be used to highlight potential complementary health approaches to recommend for patients and pertinent counseling points.

Recent Updates for the Management of Urinary Tract Infections 

In 2025, new treatment guidelines were released that updated the definitions for uncomplicated urinary tract infections (uUTIs) from complicated UTIs (cUTIs), as well as updated the treatment recommendations for cUTIs, such as pyelonephritis.  Healthcare providers must be familiar with these new recommendations to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the development of antimicrobial resistance.

Controlled Substances: Prescribing and Dispensing Within the Law

There are numerous state and federal laws/regulations related to controlled substances. These can be confusing to prescribers and dispensers. This program aims to provide clarification regarding those rules and regulations as well as best practices.

Continuous Glucose Monitoring Education for the Practicing Pharmacist

Continuous glucose monitors (CGM) continue to gain use among people with diabetes. Pharmacists are uniquely positioned to help patients selection which CGM to use and support the interpretation of the glucose data that is retrieved from CGMs, which ultimately can impact care. This webinar will compare differences between CGMs and traditional blood glucose monitoring, discussion differences among CGM products, and offer methods to analyze data downloads from CGMs.

Advancing Tobacco and Nicotine Cessation Strategies for Low Socioeconomic Communities in Alabama

This recorded webinar will provide information for priContinuous Glucose Monitoring Education for the Practicing Pharmacistmary care providers and pharmacies on how to help patients quit smoking and vaping.

Billing and Reimbursement for Community-Based, Pharmacist-Provided Clinical Services

This program equips pharmacists with essential knowledge and practical strategies to navigate billing and reimbursement for clinical services in community settings. Learners will explore the significance of provider status, distinguish between pharmacy and medical billing practices, and gain familiarity with key billing codes. The course also covers incident-to billing requirements, supervision models, and alternative revenue-generating approaches to support sustainable clinical service delivery.

Dementia and Medications: Unraveling the Complexities for Better Care

This program will provide a brief overview of different types of dementia and possible treatment options for each. The primary focus for this presentation will be on the management of Alzheimer dementia. This program will also address behavioral and psychological symptoms of dementia (BPSD) and possible treatment options for BPSD.

The Silver Lining: Navigating Diabetes in Older Adults

Approximately 11% of adults in the United States have diabetes and ~29% of adults that are greater than or equal to 65 years of age have diabetes. Annually the American Diabetes Association updates their Standards of Medical Care in Diabetes, including specific recommendations for older adults, while other endocrine organizations periodically update their treatment algorithms. Most recently, the International Geriatric Diabetes Society published recommendations. These evidence-based clinical practice recommendations are commonly utilized to provide comprehensive management for persons with diabetes. This presentation will discuss evidence-based options for the management of type 2 diabetes in the patient cases incorporated.

Optimizing Cardiovascular Care in Older Adults

As the population ages, the prevalence of cardiovascular disease (CVD) among older adults continues to rise, presenting unique challenges in clinical management. Pharmacists play a critical role in managing medications for older adults, who often present with multiple chronic conditions, including CVD, cognitive impairment, and frailty. This presentation equips pharmacists with the knowledge and skills to deliver patient-centered, evidence-based care for older adults with CVD. Attendees will explore therapeutic strategies tailored to the aging population, including the impact of functional status, comorbidities, and complexities of polypharmacy on management of CVD in older persons.